Mexico’s Genomma Lab Internacional SAB de CV reported OTC sales up by 7.5% to MXN1.48bn ($75.4m) in the second quarter, as turnover improved at single-digit rates in all three of its reporting regions.
Consumer Health Results Roundup: Genomma, Ipsen And Taisho
Mexico's Genomma enjoys good growth in the second quarter, while Japan's Taisho records a steady start to its new financial year. Meanwhile, France's Ipsen endures a difficult period as its biggest OTC brand falters.
